Literature DB >> 7148505

Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland.

J T Salonen.   

Abstract

The use of oral contraceptives (OC) and smoking habits were studied by using a questionnaire in a random population sample of women from two counties of Eastern Finland in 1972. The participation rate was 95%. Data on use of OC and smoking were collected for 2,653 women aged 35-49 years. During the next seven years, 27 of them had developed an acute myocardial infarction (AMI). Smokers had a 2.6-fold (95% confidence interval (CI)=1.2-6.0) crude risk of developing AMI compared with non-smokers. Women taking OC had a 1.3-fold (95% CI = 0.4-6.9) risk of developing AMI compared with those who did not. Women who both smoked and used OC had a 7.2-fold (95% CI = 2.1-24.7) risk of AMI compared with non-smokers and non-users of OC. The results indicate that use of OC is associated with an excessive risk of AMI among female smokers.

Entities:  

Keywords:  Age Factors; Behavior; Biology; Cardiovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Finland; Heart Diseases; High Risk Women; Northern Europe; Oral Contraceptives--side effects; Physiology; Population; Population Characteristics; Prospective Studies; Reproduction; Research Methodology; Scandinavia; Smoking; Studies

Mesh:

Substances:

Year:  1982        PMID: 7148505     DOI: 10.1111/j.0954-6820.1982.tb03186.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

Review 1.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives.

Authors:  P C Hannaford; V Owen-Smith
Journal:  BMJ       Date:  1998-03-28

Review 2.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

Review 3.  Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.

Authors:  Omosalewa O Lalude
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

4.  Contraception in patients with heart failure.

Authors:  Tara Sedlak; C Noel Bairey Merz; Chrisandra Shufelt; Kimberly D Gregory; Michele A Hamilton
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

5.  Urinary excretion of free noradrenaline and adrenaline related to age, sex and hypertension in 265 individuals.

Authors:  M Lehmann; J Keul
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

Review 6.  Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Authors:  Rachel E J Roach; Frans M Helmerhorst; Willem M Lijfering; Theo Stijnen; Ale Algra; Olaf M Dekkers
Journal:  Cochrane Database Syst Rev       Date:  2015-08-27

Review 7.  Sex differences in cardiovascular disease - Impact on care and outcomes.

Authors:  K H Humphries; M Izadnegahdar; T Sedlak; J Saw; N Johnston; K Schenck-Gustafsson; R U Shah; V Regitz-Zagrosek; J Grewal; V Vaccarino; J Wei; C N Bairey Merz
Journal:  Front Neuroendocrinol       Date:  2017-04-18       Impact factor: 8.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.